Privacy Policy
Signals Blog

Contributors

Categories

Ada Lovelace Day: celebrating women in STEM

Can you name five historically influential women in the STEM fields (science, technology, engineering and medicine)? What about three? I recently asked myself this question and found that I struggled to come up with names, despite the formal training I’ve received in...

Right Turn: “Comic” twist on CRISPR

There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these...

Taking appropriate steps towards gene editing in Canada

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in...

A new style of MSC immunotherapy – Instructions included

If you have been following stem cell news lately, you know that there have been several recent Food and Drug Administration (FDA) meetings regarding how to classify stem cells, which ultimately affects if and how they will be regulated. There are many medical...